#BEGIN_DRUGCARD DB02368

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
49002

# Chemical_Formula:
C8H15N3O4

# Chemical_IUPAC_Name:
(2S)-5-(carbamoylamino)-2-acetamidopentanoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
N-Acetyl-L-Citrulline

# HET_ID:
OLN

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C8H15N3O4/c1-5(12)11-6(7(13)14)3-2-4-10-8(9)15/h6H,2-4H2,1H3,(H,11,12)(H,13,14)(H3,9,10,15)/t6-/m0/s1

# InChI_Key:
InChIKey=WMQMIOYQXNRROC-LURJTMIESA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2368

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
217.2224

# Molecular_Weight_Mono:
217.106255983

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1YH1

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-2

# Predicted_LogS:
-1.8

# Predicted_Water_Solubility:
3.57e+00 g/l

# Primary_Accession_No:
DB02368

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
656979

# PubChem_Substance_ID:
46506512

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02432

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CC(=O)N[C@@H](CCCNC(N)=O)C(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:21:04 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasm (Probable)

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
AE012332

# Drug_Target_1_GenBank_ID_Protein:
21113385

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
argF'

# Drug_Target_1_Gene_Sequence:
>1020 bp
TCACGGGCGGCTCTGACCCACCAGCGCTGCCATGATCGCCTTCTGCACATGCAGGCGGTT
TTCGGCCTCGTCGATGGCGATGCAATTGGGCGAATCCATCACCGCATCAGTAGCCTTGAC
GTTGCGACGCAGCGGCAGGCAGTGCGAAAACACGCCGTTGTTGGTCAGCGCCATCTTGCG
TTCGTCGACGATGAAATGCTGGTACTGGTCGCGGATCGGCTTTTCCGGCTCCCAGTTGCC
GAAGAACGGCAACGCGCCCCAGCTCTTGGCGTACACCACATCGGCGCCGGCATAGGCACT
GTCGATGTCGTGGCTGACCTGCAGCGAGCCACCGCTTTCGGCCACGTTCTGCGCCGCCCA
GTCCATGTAGCGCTCGTCCAGGATGTAGTCCGGGGTCGGGCACAGCAGGGTCACGTCCAT
GCCCATGCGCGTGGCGATGGTCAGTGCCGAATTGGCTACCGCGGTGTTCAACGGCTTGGG
GTGGTAGGTCCAGGTCAACACGTACTTCTTGCCGCGCAGGTCCGGGGTGCCGAAATGCTC
CTGCAGCGCCAGCGCGTGCGCCAGCTCCTGGCACGGGTGGGTAATGGTCTCCATGTTGAT
CACCGGCACCGGCGAATACTTGGCAAAGCTCTTGAGCACCTGGTCTTCGCGGTCCTTGGA
CCAGTCGACGAACTTCGGGAACGCACGCACTCCGATCAGGTCGACGTAGCGCCCCAGCAC
GCGCGCCACCTCGGCGATGTGCTCCTCGGTATCGCCGTCCATCACCGTGCCCAGGTTGAA
TTCGATCGGCCACGCATCCTTGCCCGGCTGCAGCACCACCGCATGCCCACCCAGCTGGAA
CGCGCCCAGCTCGAAGCTGGTGCGGGTCCGCATGGACGGGTTGAAGAACACCAGCGCGAT
CGACTTGCCCTTCAGCTCGCTTCCCAGCTTGTTGCGTTTGAACAACGCGGCCTGGGTCAA
CAGCGCATCCAGTTCGGCGCGGCTCCAGTCCTGGGTGTTCAAGAAGTGCTTCAGTGACAT

# Drug_Target_1_General_Function:
Amino acid transport and metabolism

# Drug_Target_1_General_References:
12024217	da Silva AC, Ferro JA, Reinach FC, Farah CS, Furlan LR, Quaggio RB, Monteiro-Vitorello CB, Van Sluys MA, Almeida NF, Alves LM, do Amaral AM, Bertolini MC, Camargo LE, Camarotte G, Cannavan F, Cardozo J, Chambergo F, Ciapina LP, Cicarelli RM, Coutinho LL, Cursino-Santos JR, El-Dorry H, Faria JB, Ferreira AJ, Ferreira RC, Ferro MI, Formighieri EF, Franco MC, Greggio CC, Gruber A, Katsuyama AM, Kishi LT, Leite RP, Lemos EG, Lemos MV, Locali EC, Machado MA, Madeira AM, Martinez-Rossi NM, Martins EC, Meidanis J, Menck CF, Miyaki CY, Moon DH, Moreira LM, Novo MT, Okura VK, Oliveira MC, Oliveira VR, Pereira HA, Rossi A, Sena JA, Silva C, de Souza RF, Spinola LA, Takita MA, Tamura RE, Teixeira EC, Tezza RI, Trindade dos Santos M, Truffi D, Tsai SM, White FF, Setubal JC, Kitajima JP: Comparison of the genomes of two Xanthomonas pathogens with differing host specificities. Nature. 2002 May 23;417(6887):459-63.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2776

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
37874

# Drug_Target_1_Name:
N-acetylornithine carbamoyltransferase

# Drug_Target_1_Number_of_Residues:
339

# Drug_Target_1_PDB_ID:
1YH1

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00185	OTCace
PF02729	OTCace_N

# Drug_Target_1_Protein_Sequence:
>N-acetylornithine carbamoyltransferase
MSLKHFLNTQDWSRAELDALLTQAALFKRNKLGSELKGKSIALVFFNPSMRTRTSFELGA
FQLGGHAVVLQPGKDAWPIEFNLGTVMDGDTEEHIAEVARVLGRYVDLIGVRAFPKFVDW
SKDREDQVLKSFAKYSPVPVINMETITHPCQELAHALALQEHFGTPDLRGKKYVLTWTYH
PKPLNTAVANSALTIATRMGMDVTLLCPTPDYILDERYMDWAAQNVAESGGSLQVSHDID
SAYAGADVVYAKSWGALPFFGNWEPEKPIRDQYQHFIVDERKMALTNNGVFSHCLPLRRN
VKATDAVMDSPNCIAIDEAENRLHVQKAIMAALVGQSRP

# Drug_Target_1_Reaction:
carbamoyl phosphate + N2-acetyl-L-ornithine = phosphate + N-acetyl-L-citrulline

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Catalyzes the convertion of N-acetylornithine to N- acetylcitrulline in an alternative arginine biosynthesis pathway. The enzyme has no activity with ornithine

# Drug_Target_1_SwissProt_ID:
Q8P8J2

# Drug_Target_1_SwissProt_Name:
AOTC_XANCP

# Drug_Target_1_Synonyms:
AOTCase
EC 2.1.3.9

# Drug_Target_1_Theoretical_pI:
6.59

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB02368
